To Compare Connective Tissue Grafts and Acellular Dermal Matrix Grafts at the Time of Lateral Ridge Augmentation Procedure.
Conditions:   Ridge Augmentation;   Alveolar Mucosa;   Dental Implant Interventions:   Procedure: Connective tissue graft at time of bone graft;   Procedure: Acellular Demal Matrix at time of bone graft;   Procedure: No soft tissue grafting at time of bone graft Sponsor:   University of Alabama at Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2018 Category: Research Source Type: clinical trials

Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
Condition:   Skin Health Interventions:   Dietary Supplement: Beauty From Within;   Other: Placebo Sponsors:   Pharmanex;   Dermatology Consulting Services, High Point NC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Conditions:   Pain;   Pharmacokinetics Intervention:   Drug: Transtec 35 µg/hour transdermal patch Sponsor:   Grünenthal GmbH Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Condition:   Atopic Dermatitis Interventions:   Drug: Crisaborole;   Device: Scratch sensor Sponsors:   Northwestern University;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Conditions:   Pain;   Pharmacokinetics Intervention:   Drug: Transtec 35 µg/hour transdermal patch Sponsor:   Grünenthal GmbH Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Condition:   Atopic Dermatitis Interventions:   Drug: Crisaborole;   Device: Scratch sensor Sponsors:   Northwestern University;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Conditions:   Pain;   Pharmacokinetics Intervention:   Drug: Transtec 35 µg/hour transdermal patch Sponsor:   Grünenthal GmbH Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Condition:   Atopic Dermatitis Interventions:   Drug: Crisaborole;   Device: Scratch sensor Sponsors:   Northwestern University;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Conditions:   Pain;   Pharmacokinetics Intervention:   Drug: Transtec 35 µg/hour transdermal patch Sponsor:   Grünenthal GmbH Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Condition:   Atopic Dermatitis Interventions:   Drug: Crisaborole;   Device: Scratch sensor Sponsors:   Northwestern University;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Conditions:   Pain;   Pharmacokinetics Intervention:   Drug: Transtec 35 µg/hour transdermal patch Sponsor:   Grünenthal GmbH Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Condition:   Atopic Dermatitis Interventions:   Drug: Crisaborole;   Device: Scratch sensor Sponsors:   Northwestern University;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
Conditions:   Quality of Life;   Atopic Dermatitis Intervention:   Other: whole body cryostimulation Sponsor:   University School of Physical Education, Krakow, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2018 Category: Research Source Type: clinical trials

An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
Condition:   Atopic Dermatitis Intervention:   Drug: FB825, FB825-15D11, Anti-CemX Sponsor:   Fountain Biopharma Inc. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2018 Category: Research Source Type: clinical trials